Reduced production of IL-2 demonstrated in patients with SLE enhances the expansion of Th17 population which promotes local inflammation and recruitment of immunocytes in part due to the increased production of IL-17 [40]. The gene discussed is IL2; the disease is systemic lupus erythematosus.